| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/14/2005 | EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 09/14/2005 | EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF |
| 09/14/2005 | CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 09/14/2005 | CN1668721A Immunoadhesin comprising a glycoprotein VI domain |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668643A Method for using glucan-haemoglobin conjugale as blood substitute |
| 09/14/2005 | CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/14/2005 | CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/14/2005 | CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor |
| 09/14/2005 | CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 09/14/2005 | CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/14/2005 | CN1668333A Stable pharmaceutical composition comprising erythropoietin |
| 09/14/2005 | CN1668316A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668290A Modified amino acid for the inhibition of platelet aggregation |
| 09/14/2005 | CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea |
| 09/14/2005 | CN1666752A Medicine for blood generation and preparing method thereof |
| 09/14/2005 | CN1219057C Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 09/14/2005 | CN1218965C Sodium alginate sulfuric ester and preparation method and use thereof |
| 09/14/2005 | CN1218964C Urushi polysaccharide sulfation and its preparation method and uses |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/14/2005 | CN1218747C Medicinal use of agkistrodon acutus thrombase for treating hemorrhagic disease |
| 09/14/2005 | CN1218712C Medicine for treating aplastic anemia |
| 09/14/2005 | CN1218700C Usage of sulfonylureas derivant in the preparing process of blood vessel embolism disease treating medicine |
| 09/14/2005 | CN1218695C Anti-platelet medicine and its use |
| 09/13/2005 | US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/13/2005 | US6943179 Biurethane derivatives |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082847A1 Bicyclo derivative |
| 09/09/2005 | WO2005082384A1 Artificial physiological salt solution and process for producing the same |
| 09/09/2005 | WO2005082383A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | WO2005082378A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | CA2558155A1 Casein derived peptides and therapeutic uses thereof |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2557531A1 Artificial physiological salt solution and manufacturing method for same |
| 09/09/2005 | CA2556053A1 Administration of enoxaparin sodium to patients with severe renal impairment |
| 09/09/2005 | CA2548771A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | CA2548770A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/08/2005 | US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies |
| 09/08/2005 | US20050197493 Fibrinogen purification |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197372 Use of valsartan or its metabolite to inhibit platelet aggregation |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197296 Agents for preventing and treating thrombocytopenia |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050197281 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 09/08/2005 | US20050196401 Energy-activated targeted cancer therapy |
| 09/08/2005 | US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 09/08/2005 | US20050196394 Monoclonal antibodies as well as homologues, analogues, and modified and derived forms thereof, immunoglobin fab fragments, single chain antibodies; treating pathological inflammation and autoimmune diseases |
| 09/08/2005 | DE102004009400A1 Fibrinogen Reinigung Fibrinogen purification |
| 09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
| 09/07/2005 | EP1570871A1 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury |
| 09/07/2005 | EP1569927A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/07/2005 | EP1569692A2 Betaine and salicylic acid compositions |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569639A2 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/07/2005 | EP1492767B1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1289953B1 Serine protease inhibitors |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1140026B1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 09/07/2005 | EP1013278B1 The extract of pine needle and the use thereof |
| 09/07/2005 | CN1665925A Factor VII or VIIa polypeptide variants |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665554A Compounds and method for coating surfaces in a haemocompatible manner |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665496A Use of epa and dha in secondary prevention |
| 09/07/2005 | CN1663597A Qi-invigorating, blood-nourishing medicinal composition and its preparing method |
| 09/07/2005 | CN1663572A Microcrystallite asshide capsule and its hypothermia preparation method |
| 09/07/2005 | CN1663564A Formulation for preventing and treating thrombus disease |
| 09/07/2005 | CN1218041C Lumbricus kinase of electrophoretical purity and its prepn and use |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/01/2005 | WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement |
| 09/01/2005 | WO2005080385A1 Indanol derivative |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/01/2005 | US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 09/01/2005 | US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/01/2005 | US20050192307 Benzimidazolone compounds |
| 09/01/2005 | US20050192304 Rho-kinase inhibitors |